Renal cell carcinoma future or investigational therapies

In November 2006, it was announced that a vaccine had been developed and tested with very promising results.(See [2]) The new vaccine, called TroVax, works by harnessing the patient’s own immune system to fight the disease. Oxford BioMedica[3]. Further vaccine trials are underway.